Relationship between apoptosis regulator proteins (bcl-2 and p53) and Gleason score in prostate cancer
- PMID: 11692148
- DOI: 10.1007/BF03032351
Relationship between apoptosis regulator proteins (bcl-2 and p53) and Gleason score in prostate cancer
Abstract
Cellular proliferation programmed cell death (apoptosis) are associated with tumor growth in general, and prostate cancer growth in particular. The aim of this study was to examine the expression of the apoptosis regulating genes bcl-2 and p53 and Gleason score in core needle biopsy specimens of prostate cancer using immunohistochemistry. We studied bcl-2 and p53 expression in 12 cases of low grade (Gleason score 2-5), 12 cases of intermediate grade (Gleason score 6-7) and 8 cases of high grade (Gleason score 8-10) prostate cancer. Overexpression of bcl-2 was noted in 3 of 32 patients (9.32%). One of them was high grade; others were intermediate grades. Expression of p53 was observed in 3 of low grades; others were high grade. The statistical analysis of present data suggest that there is no significant relation between p53 and bcl-2 expression and Gleason score in prostate cancer.
Similar articles
-
Androgen receptor expression in relation to apoptosis and the expression of cell cycle related proteins in prostate cancer.Pathol Oncol Res. 2004;10(1):37-41. doi: 10.1007/BF02893407. Epub 2004 Mar 18. Pathol Oncol Res. 2004. PMID: 15029260
-
Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer.Int J Cancer. 2009 May 1;124(9):2116-23. doi: 10.1002/ijc.24174. Int J Cancer. 2009. PMID: 19117060
-
Correlation between histological type and immunohistochemical profile of prostate cancer and gleason scale gradation.Exp Oncol. 2009 Dec;31(4):246-9. Exp Oncol. 2009. PMID: 20010526
-
Apoptosis regulating genes in prostate cancer (review).Oncol Rep. 1998 May-Jun;5(3):553-7. doi: 10.3892/or.5.3.553. Oncol Rep. 1998. PMID: 9538152 Review.
-
Prognostic markers in clinically localized prostate cancer.Tech Urol. 1998 Mar;4(1):35-42. Tech Urol. 1998. PMID: 9568775 Review.
Cited by
-
Role of cyclin D1 immunoreactivity and AgNOR staining in the evaluation of benign and malignant lesions of the prostate.Prostate Int. 2014;2(2):90-6. doi: 10.12954/PI.14041. Epub 2014 Jun 30. Prostate Int. 2014. PMID: 25032195 Free PMC article.
-
The effects of melatonin and the antioxidant defence system on apoptosis regulator proteins (Bax and Bcl-2) in experimentally induced varicocele.Urol Res. 2004 Jun;32(3):204-8. doi: 10.1007/s00240-004-0403-0. Epub 2004 Feb 6. Urol Res. 2004. PMID: 15205854
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous